How many drugs treat Ocular Itching?

Drug Landscape tracks 4 marketed treatments for Ocular Itching (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/ocular-itching.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Ocular Itching — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ocular Itching (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Ocular Itching, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Elestat	EPINASTINE	AbbVie	Adrenergic Receptor Agonist	Histamine H1 receptor	2003-01-01
Alocril	NEDOCROMIL	AbbVie	Mast Cell Stabilizer	G-protein coupled receptor 35	1992-01-01
Phenazoline	ANTAZOLINE	Novartis	antazoline	Histamine H1 receptor	1990-01-01
Naphcon Forte	NAPHAZOLINE	Novartis	Non-Standardized Chemical Allergen [EPC]	Alpha-2A adrenergic receptor	1971-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AbbVie · 2 drugs in Ocular Itching
Novartis · 2 drugs in Ocular Itching

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Ocular Itching:

Cite this brief

Drug Landscape (2026). Ocular Itching — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ocular-itching. Accessed 2026-06-10.

Ocular Itching full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing